As an increasingly diverse array of ADCs containing different payloads and linkers are developed to tackle different tumor targets, understanding how bioconjugate design contributes and accumulates to performance in the clinic is vital to set up your therapy for success.

Take part in this workshop exploring recent case-study examples to contextualize and understand the performance of different ADC designs to understand what really makes a clinically effective ADC.

Workshop highlights include:

• Accurately correlating and characterizing antibody, linker, payload, and overall conjugate contributions to ADC clinical performance
• Delving into ADC clinical case studies to evaluate differentiated design impact on safety and efficacy profiles to understand what makes a clinically effective ADC
• Finding the right match: Optimizing ADC design to improve payload target pairing